Trial site
Clinical Pharmacology of Miami
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Obesity6 trials
- Type 2 diabetes4 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Type 1 diabetes2 trials
- Alzheimer disease1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Phase
- Phase 19 trials
- Phase 21 trial
- Status
- Completed5 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company6 trials
- AdipoPharma LLC1 trial
- Alveus Therapeutics, Inc.1 trial
- Foundation for the National Institutes of Health1 trial
- Hua Medicine Limited1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes
Recruiting
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Active, not recruiting
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 1 diabetes2 recruiting
- Type 2 diabetes2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Liver cirrhosis1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
Completed
Completed
A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 12 Nov 2026